MPI Research Breaks Ground on New Imaging Center
MPI's new Imaging Center is set to open in Spring 2014 at the company's headquarters in Michigan.
MPI Research
, in partnership with INVICRO and 3D Imaging, held the groundbreaking for its new Imaging Center, which is set to open in Spring 2014 at the MPI Research corporate headquarters in Mattawan, Michigan. Pharmaceutical researchers will have access to a cyclotron facility directly connected to vivarium, permitting drug radiolabeling and in-depth studies across a variety of animal models.
The 10,000 ft
2
, two-story imaging center is the latest joint effort between MPI, INVICRO, and 3D Imaging, which have collaborated on more than 100 imaging projects to date. The multimillion-dollar project will include INVICRO’s molecular imaging informatics team and 3D Imaging’s radiopharmaceutical group.
Many of the expanded imaging solutions, including nonhuman primate PET and CT imaging capabilities, became available in July 2013.
Source:
MPI Research
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
